JP2019518084A5 - - Google Patents

Download PDF

Info

Publication number
JP2019518084A5
JP2019518084A5 JP2019518350A JP2019518350A JP2019518084A5 JP 2019518084 A5 JP2019518084 A5 JP 2019518084A5 JP 2019518350 A JP2019518350 A JP 2019518350A JP 2019518350 A JP2019518350 A JP 2019518350A JP 2019518084 A5 JP2019518084 A5 JP 2019518084A5
Authority
JP
Japan
Prior art keywords
topical formulation
histidine
formulation according
skin
nucleophile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019518350A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019518084A (ja
JP7019684B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2017/050201 external-priority patent/WO2017215723A1/en
Publication of JP2019518084A publication Critical patent/JP2019518084A/ja
Publication of JP2019518084A5 publication Critical patent/JP2019518084A5/ja
Priority to JP2022014925A priority Critical patent/JP7220316B2/ja
Application granted granted Critical
Publication of JP7019684B2 publication Critical patent/JP7019684B2/ja
Priority to JP2022173435A priority patent/JP2022187022A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019518350A 2016-06-17 2017-06-16 尿毒症性掻痒症の治療に使用するための製剤 Active JP7019684B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022014925A JP7220316B2 (ja) 2016-06-17 2022-02-02 尿毒症性掻痒症の治療に使用するための製剤
JP2022173435A JP2022187022A (ja) 2016-06-17 2022-10-28 尿毒症性掻痒症の治療に使用するための製剤

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA201670438 2016-06-17
DKPA201670438 2016-06-17
DKPA201770225 2017-03-28
DKPA201770225 2017-03-28
PCT/DK2017/050201 WO2017215723A1 (en) 2016-06-17 2017-06-16 Formulation for use in the treatment of uremic pruritus

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022014925A Division JP7220316B2 (ja) 2016-06-17 2022-02-02 尿毒症性掻痒症の治療に使用するための製剤

Publications (3)

Publication Number Publication Date
JP2019518084A JP2019518084A (ja) 2019-06-27
JP2019518084A5 true JP2019518084A5 (cg-RX-API-DMAC7.html) 2020-07-27
JP7019684B2 JP7019684B2 (ja) 2022-02-15

Family

ID=60663348

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019518350A Active JP7019684B2 (ja) 2016-06-17 2017-06-16 尿毒症性掻痒症の治療に使用するための製剤
JP2022014925A Active JP7220316B2 (ja) 2016-06-17 2022-02-02 尿毒症性掻痒症の治療に使用するための製剤
JP2022173435A Pending JP2022187022A (ja) 2016-06-17 2022-10-28 尿毒症性掻痒症の治療に使用するための製剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022014925A Active JP7220316B2 (ja) 2016-06-17 2022-02-02 尿毒症性掻痒症の治療に使用するための製剤
JP2022173435A Pending JP2022187022A (ja) 2016-06-17 2022-10-28 尿毒症性掻痒症の治療に使用するための製剤

Country Status (11)

Country Link
US (2) US10806721B2 (cg-RX-API-DMAC7.html)
EP (2) EP3471720B1 (cg-RX-API-DMAC7.html)
JP (3) JP7019684B2 (cg-RX-API-DMAC7.html)
KR (3) KR102454777B1 (cg-RX-API-DMAC7.html)
CN (2) CN109414430B (cg-RX-API-DMAC7.html)
AU (2) AU2017283511B2 (cg-RX-API-DMAC7.html)
BR (1) BR112018076229A2 (cg-RX-API-DMAC7.html)
CA (1) CA3026620C (cg-RX-API-DMAC7.html)
ES (1) ES3006940T3 (cg-RX-API-DMAC7.html)
RU (1) RU2018146294A (cg-RX-API-DMAC7.html)
WO (1) WO2017215723A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102454777B1 (ko) * 2016-06-17 2022-10-14 드러그 딜리버리 솔루션즈 에이피에스 요독 가려움증의 치료에 사용하기 위한 제형
WO2023194400A1 (en) * 2022-04-06 2023-10-12 Mc2 Therapeutics Ltd Topical formulation for use in the treatment or prevention of itchy dry skin
EP4681722A1 (en) * 2024-07-18 2026-01-21 Institut National de la Santé et de la Recherche Médicale Methods for the treatment of inflammatory skin diseases with urocanase inhibitor

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4025645A (en) 1976-01-27 1977-05-24 Jelenko Iii Carl Non-steroid topical agent for alleviating inflammation in mammals
US5811446A (en) 1997-04-18 1998-09-22 Cytos Pharmaceuticals Llc Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
US6573302B1 (en) 1999-09-29 2003-06-03 Medical Merchandising, Inc. Cream utilizing capsaicin
US20060211754A1 (en) 2005-03-16 2006-09-21 Yu Ruey J Compositions comprising N-propanoyl derivatives of amino acids, aminocarbohydrates and derivatives thereof
US20070065396A1 (en) 2005-09-21 2007-03-22 Tracie Martyn International, Llc Topical macqui berry formulation
JP5168996B2 (ja) * 2007-04-13 2013-03-27 味の素株式会社 アミノ酸類高配合防腐水溶液
FR2916351B1 (fr) 2007-05-22 2012-12-07 Galderma Res & Dev Composition pharmaceutique comprenant au moins deux composes choisis parmi l'acide pyrrolidone-5-carboxylique, la citrulline, l'arginine et l'asparagine et leur utilisation dans le traitement de la dermatite atopique
US20090017129A1 (en) 2007-07-13 2009-01-15 Ma Or Ze Ev Dead Sea minerals enriched anti-inflammatory pharmaceutical composition for treatment of cutaneous dryness, itching, peeling and tightness, especially in hemodialysis patients and preparation and treatment methods thereof
US8337820B2 (en) 2008-02-13 2012-12-25 Bart Nieuwenhuijsen Composition of a water-soluble sunscreen preparation for acne rosacea
GB0803054D0 (en) 2008-02-20 2008-03-26 Univ Manchester Medicament
EP2373583A1 (en) 2008-07-23 2011-10-12 Fze Engsl A combined solid waste, carbon dioxide quicklime sparging, brine water, and reverse osmosis/ion exchange processes for the production of soda chemicals
FR2938193B1 (fr) * 2008-11-07 2011-08-12 Expanscience Lab Medicament ou composition dermatologique comprenant un extrait peptidique d'avocat destine au traitement et a la prevention du prupit
NZ595775A (en) 2008-12-26 2013-07-26 Glenmark Pharmaceuticals Sa Fused imidazole derivatives as trpv3 antagonist
KR100953515B1 (ko) * 2009-08-28 2010-04-21 전북대학교산학협력단 피부 가려움증 개선을 위한 조성물
DE102011110909A1 (de) * 2011-08-18 2013-02-21 Paul Hartmann Ag Zusammensetzungen mit einer die Hautbarriere verbessernden Wirkstoffkombination
EP2869897A4 (en) * 2012-07-06 2016-09-28 Univ Duke ACTIVATION OF THE TRPV4 ION CHANNEL BY PHYSICAL STIMULI AND IMPORTANT ROLE FOR TRPV4 IN ORGANIC INFLAMMATION AND JUCKREIZ
US20160008297A1 (en) 2012-08-23 2016-01-14 B.R.A.I.N. Biotechnology Research And Information Network Ag Compounds for preventing, reducing and/or alleviating itchy skin condition(s)
CN103908467B (zh) * 2013-01-05 2017-02-08 西藏博睿生物科技有限公司 一种药物组合物及制剂
WO2016086280A1 (pt) * 2014-12-04 2016-06-09 Cardoso De Gouveia Alberto Composição dermatológica e seu uso
KR102454777B1 (ko) 2016-06-17 2022-10-14 드러그 딜리버리 솔루션즈 에이피에스 요독 가려움증의 치료에 사용하기 위한 제형

Similar Documents

Publication Publication Date Title
ES2925876T3 (es) Nuevo tratamiento de las úlceras crónicas
HRP20200434T1 (hr) Stabilne vodene formulacije adalimumaba
CN108136027A (zh) 用于活性成分的基于凡士林的递送系统
JP2012236857A5 (cg-RX-API-DMAC7.html)
MX374287B (es) Formulacion que contiene virus y uso de la misma.
JP2011529038A5 (cg-RX-API-DMAC7.html)
JP2009519940A (ja) 皮膚科学的状態を処置するための組成物および方法
RU2014142038A (ru) Короткие антимикробные липопептиды
JP2015512403A5 (cg-RX-API-DMAC7.html)
US20080299228A1 (en) Topical compositions comprising a macromolecule and methods of using same
JP2010536745A5 (cg-RX-API-DMAC7.html)
SA517390331B1 (ar) تراكيب مصفوفة بوليمر موضعية تشتمل على تركيز عالي من هيالورونات الصوديوم المخمر حيوياً واستخداماتها
JP2021536502A (ja) アミノ酸ベースの栄養素の使用及びそれを含む医薬組成物
MX2013004099A (es) Conjunto de juguete de construccion.
AR065317A1 (es) Uso de quitosanos, derivados de quitosanos y una sal fisiologicamente aceptable del mismo para el tratamiento de enfermedades inflamatorias ungueales
MY191712A (en) Composition comprising at least one dry powder obtained by spray drying to increase the stability of the formulation
BR112015020443A8 (pt) formulação em pó para inalação, seus usos e seu processo de preparação, e composição farmacêutica
RU2018146294A (ru) Композиция для лечения уремического зуда
NZ719321A (en) Storage stable lyophilized tripeptide formulations
WO2016079246A1 (en) Bioadhesive films
WO2019004788A3 (ko) 브라우쏘칼콘 a를 유효성분으로 포함하는 염증성 장질환 예방 또는 치료용 약학 조성물
WO2015100348A8 (en) Keloid reduction using topical allantoin
WO2020170033A8 (en) Method for treatment of moderate to severe erythema symptoms in rosacea patients
KR20260030114A (ko) 신규한 다기능성 올리고펩타이드
WO2012140609A3 (en) System for prolonged release of cosmetic agents